Print Page  Close Window

SEC Filings

S-1
VITAE PHARMACEUTICALS, INC filed this Form S-1 on 08/12/2014
Entire Document
 

 

IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first above written.

 

 

INVESTORS:

 

 

 

 

VENROCK ASSOCIATES,

 

 

by a General Partner

 

VENROCK ASSOCIATES III, L.P.,

 

 

by its General Partner, Venrock Management III LLC

 

VENROCK ENTREPRENEURS FUND III, L.P.,

 

 

by its General Partner, VEF Management III LLC

 

 

 

 

 

 

 

By

/s/ Bryan Roberts

 

 

As a General Partner or Member

 

 

 

 

 

 

 

Address:

2494 Sand Hill Road, Suite 200

 

 

Menlo Park, CA 94025

 

SIGNATURE PAGE TO VITAE PHARMACEUTICALS, INC.
AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT

 


 

IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first above written.

 

 

INVESTORS:

 

 

 

 

NEW ENTERPRISE ASSOCIATES 10,

 

LIMITED PARTNERSHIP

 

 

 

By:

NEA Partners 10, Limited Partnership

 

 

its General Partner

 

 

 

 

/s/ Charles W. Newhall III

 

By:

General Partner

 

Print Name:

 

 

 

 

NEA VENTURES 2001, LIMITED

 

PARTNERSHIP

 

 

 

/s/ Pamela J. Clark

 

By:

General Partner

 

Print Name: Pamela J. Clark

 

 

 

Address:

1119 St. Paul Street

 

Baltimore, MD 21202

 

SIGNATURE PAGE TO VITAE PHARMACEUTICALS, INC.
AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT